Transcatheter Mitral Valve Repair or Replacement: Competitive or Complementary?

Zhang Xiling, Thomas Puehler, Lars Sondergaard, Derk Frank, Hatim Seoudy, Baland Mohammad, Oliver J. Müller, Stephanie Sellers, David Meier, Janarthanan Sathananthan, Georg Lutter*

*Corresponding author for this work

Research output: Contribution to journalReviewResearchpeer-review

5 Citations (Scopus)
10 Downloads (Pure)

Abstract

Over the last two decades, transcatheter devices have been developed to repair or replace diseased mitral valves (MV). Transcatheter mitral valve repair (TMVr) devices have been proven to be efficient and safe, but many anatomical structures are not compatible with these technologies. The most significant advantage of transcatheter mitral valve replacement (TMVR) over transcatheter repair is the greater and more reliable reduction in mitral regurgitation. However, there are also potential disadvantages. This review introduces the newest TMVr and TMVR devices and presents clinical trial data to identify current challenges and directions for future research.

Original languageEnglish
Article number3377
JournalJournal of Clinical Medicine
Volume11
Issue number12
ISSN2077-0383
DOIs
Publication statusPublished - 2022

Bibliographical note

Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.

Keywords

  • access
  • approach
  • endovascular
  • mitral insufficiency
  • mitral regurgitation
  • percutaneous
  • transcatheter mitral valve repair
  • transcatheter mitral valve replacement
  • transcatheter technology
  • transluminal

Cite this